Goldman Sachs’s Applied Therapeutics APLT Stock Holding History

Goldman Sachs’s Portfolio APLT Stock Details APLT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-120,000	Closed	-$103K	–	6046
2024 Q4	$103K	Buy	120,000 +400	+0.3%	+$2.51K	﹤0.01%	5762
2024 Q3	$1.02M	Buy	+119,600	New	+$705K	﹤0.01%	4621

Goldman Sachs's APLT Position: Q1 2026 in Review

Goldman Sachs sold out of Applied Therapeutics (APLT) in Q1 2026, closing a stake of 146,219 shares — an estimated $14.6K sold.

Goldman Sachs first reported a position in APLT in Q2 2019 and held it in 21 quarters. The position peaked at $6.95M in Q3 2024. 0 funds tracked by Wall St. Rank hold APLT as of Q1 2026.

Goldman Sachs reported no remaining Applied Therapeutics position as of Q1 2026 after selling out during the quarter.
Goldman Sachs sold 146,219 Applied Therapeutics shares in Q1 2026, an estimated $14.6K.
Goldman Sachs first reported a position in Applied Therapeutics in Q2 2019 and held it in 21 quarters.
Goldman Sachs's Applied Therapeutics position peaked at $6.95M in Q3 2024.
0 funds tracked by Wall St. Rank held Applied Therapeutics as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.